150 related articles for article (PubMed ID: 6344147)
1. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
Whittle BJ; Moncada S; Mullane K; Vane JR
Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
[TBL] [Abstract][Full Text] [Related]
2. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
Hamid S; Whittle BJ
Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
4. Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.
Narumiya S; Toda N
Br J Pharmacol; 1985 Jun; 85(2):367-75. PubMed ID: 2992661
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
Hamid-Bloomfield S; Whittle BJ
Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
[TBL] [Abstract][Full Text] [Related]
6. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
Whittle BJ; Moncada S; Vane JR
Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
[TBL] [Abstract][Full Text] [Related]
7. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
Whittle BJ; Moncada S; Whiting F; Vane JR
Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
[TBL] [Abstract][Full Text] [Related]
8. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
[TBL] [Abstract][Full Text] [Related]
9. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
Whittle BJ; Hamid S; Lidbury P; Rosam AC
Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
[No Abstract] [Full Text] [Related]
10. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs.
Tynan SS; Andersen NH; Wills MT; Harker LA; Hanson SR
Prostaglandins; 1984 May; 27(5):683-96. PubMed ID: 6087417
[TBL] [Abstract][Full Text] [Related]
11. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Ubatuba FB; Moncada S; Vane JR
Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
[TBL] [Abstract][Full Text] [Related]
12. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and platelet aggregation.
Smith JB
Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and inhibitory activity on platelet aggregation of 13'-aza and other omega-chain modified BW245C analogues.
Barraclough P; Brockwell M; Caldwell AG; Demaine DA; Harris CJ; King WR; Stepney RJ; Wharton CJ; Whittle BJ
Arch Pharm (Weinheim); 1994 May; 327(5):307-17. PubMed ID: 8010883
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors.
Town MH; Casals-Stenzel J; Schillinger E
Prostaglandins; 1983 Jan; 25(1):13-28. PubMed ID: 6302737
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
Bult H; Wechsung E; Houvenaghel A; Herman AG
Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
[No Abstract] [Full Text] [Related]
17. AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
Keery RJ; Lumley P
Br J Pharmacol; 1988 Jul; 94(3):745-54. PubMed ID: 2460179
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
20. The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system.
Weeks JR
Acta Biol Med Ger; 1978; 37(5-6):707-14. PubMed ID: 369253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
